59 related articles for article (PubMed ID: 38591958)
1. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma.
Chen X; Mohammed AF; Li C
Clin Appl Thromb Hemost; 2024; 30():10760296231221535. PubMed ID: 38591958
[TBL] [Abstract][Full Text] [Related]
3. Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation.
Chen Y; Yang Y; Zhang XY; Fan QS; Li X; Xin YJ; Cao XJ; Wang YN; Zhou X
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1551-1560. PubMed ID: 34036405
[TBL] [Abstract][Full Text] [Related]
4. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
6. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.
Xia W; Ke Q; Wang Y; Wang W; Zhang M; Shen Y; Wu J; Xu X; Zheng S
World J Surg Oncol; 2015 Feb; 13():60. PubMed ID: 25885777
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
8. A Novel Inflammatory Marker for the Diagnosis of Hashimoto's Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio.
Erge E; Kiziltunc C; Balci SB; Atak Tel BM; Bilgin S; Duman TT; Aktas G
Diseases; 2023 Jan; 11(1):. PubMed ID: 36810529
[TBL] [Abstract][Full Text] [Related]
9. Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors.
Huang R; Zheng Y; Zou W; Liu C; Liu J; Yue J
J Immunol Res; 2022; 2022():3781109. PubMed ID: 36033384
[TBL] [Abstract][Full Text] [Related]
10. Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child-Pugh A.
Zhou J; Yang D
Curr Oncol; 2022 Aug; 29(8):5800-5809. PubMed ID: 36005195
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy.
Park Y; Chang AR
Korean J Gastroenterol; 2022 Jun; 79(6):252-259. PubMed ID: 35746839
[TBL] [Abstract][Full Text] [Related]
12. Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients.
Ratnasari N; Lestari P; Renovaldi D; Raditya Ningsih J; Qoriansas N; Wardana T; Hakim S; Signa Aini Gumilas N; Indrarti F; Triwikatmani C; Bayupurnama P; Setyo Heriyanto D; Astuti I; Mubarika Harjana S
PLoS One; 2022; 17(2):e0263298. PubMed ID: 35157721
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Values of Neutrophil-to-lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study.
Mahassadi AK; Anzouan-Kacou Kissi H; Attia AK
Hepat Med; 2021; 13():123-134. PubMed ID: 34938131
[TBL] [Abstract][Full Text] [Related]
14. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.
Khalid A; Ali Jaffar M; Khan T; Abbas Lail R; Ali S; Aktas G; Waris A; Javaid A; Ijaz N; Muhammad N
Hematology; 2021 Dec; 26(1):529-542. PubMed ID: 34334100
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
